High-iron consumption impairs growth and causes copper-deficiency anemia in weanling Sprague-Dawley rats

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Ha, Jung Heun ^a   Doguer, Caglar ^a   Wang, Xiaoyu ^a   Flores, Shireen R ^a   Collins, James F ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; ERYTHROFERRONE; ERYTHROPOIETIN; HEPCIDIN; HORMONE; IRON; MESSENGER RNA; UNCLASSIFIED DRUG; COPPER; IRON DERIVATIVE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; CONTROLLED STUDY; COPPER DEFICIENCY ANEMIA; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GROWTH DISORDER; HEART VENTRICLE HYPERTROPHY; IRON DEFICIENCY; IRON OVERLOAD; MALE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; ADVERSE EFFECTS; ANALYSIS; ANIMAL; ANIMAL FOOD; BLOOD; CHEMICALLY INDUCED; DEFICIENCY; DIET; GROWTH, DEVELOPMENT AND AGING; NEWBORN; SPRAGUE DAWLEY RAT; WEANING;

ANEMIA; ANIMAL FEED; ANIMALS; ANIMALS, NEWBORN; COPPER; DIET; IRON COMPOUNDS; MALE; RATS; RATS, SPRAGUE-DAWLEY; WEANING;

EID: 84984905371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161033     Document Type: Article

References (50)

1. Gulec S, Collins JF. Molecular mediators governing iron-copper interactions. Annu Rev Nutr. 2014; 34:95-116. doi: 10.1146/annurev-nutr-071812-161215
2. Fox PL. The copper-iron chronicles: The story of an intimate relationship. Biometals. 2003; 16(1):9-40. .
3. Ravia JJ, Stephen RM, Ghishan FK, Collins JF. Menkes Copper ATPase (Atp7a) is a novel metalresponsive gene in rat duodenum, and immunoreactive protein is present on brush-border and basolateral membrane domains. J Biol Chem. 2005; 280(43):36221-7. doi: 10.1074/jbc.M506727200.
4. Collins JF, Franck CA, Kowdley KV, Ghishan FK. Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. Am J Physiol Gastrointest Liver Physiol. 2005; 288(5):G964-71. doi: 10.1152/ajpgi.00489.2004 .
5. Gulec S, Collins JF. Investigation of iron metabolism in mice expressing a mutant Menke's copper transporting ATPase (Atp7a) protein with diminished activity (Brindled; Mo (Br) (/y)). PLoS One. 2013; 8 (6):e66010. doi: 10.1371/journal.pone.0066010.
6. Xie L, Collins JF. Transcriptional regulation of the Menkes copper ATPase (Atp7a) gene by hypoxiainducible factor (HIF2{alpha}) in intestinal epithelial cells. Am J Physiol Cell Physiol. 2011; 300(6): C1298-305. doi: 10.1152/ajpcell.00023.2011
7. Xie L, Collins JF. Transcription factors Sp1 and Hif2alpha mediate induction of the copper-Transporting ATPase (Atp7a) gene in intestinal epithelial cells during hypoxia. J Biol Chem. 2013; 288(33):23943-52. doi: 10.1074/jbc.M113.489500
8. Jiang L, Garrick MD, Garrick LM, Zhao L, Collins JF. Divalent metal transporter 1 (Dmt1) mediates copper transport in the duodenum of iron-deficient rats and when overexpressed in iron-deprived HEK-293 cells. J Nutr. 2013; 143(12):1927-33. doi: 10.3945/jn.113.181867
9. Collins JF, Hu Z, Ranganathan PN, Feng D, Garrick LM, Garrick MD, et al. Induction of arachidonate 12-lipoxygenase (Alox15) in intestine of iron-deficient rats correlates with the production of biologically active lipid mediators. Am J Physiol Gastrointest Liver Physiol. 2008; 294(4):G948-62. doi: 10.1152/ajpgi.00274.2007 .
10. Ranganathan PN, Lu Y, Jiang L, Kim C, Collins JF. Serum ceruloplasmin protein expression and activity increases in iron-deficient rats and is further enhanced by higher dietary copper intake. Blood. 2011; 118(11):3146-53. doi: 10.1182/blood-2011-05-352112
11. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993; 123(11):1939-51. .
12. Reeves PG, Rossow KL, Lindlauf J. Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J Nutr. 1993; 123 (11):1923-31. .
13. Bacon BR, Tavill AS, Brittenham GM, Park CH, Recknagel RO. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest. 1983; 71(3):429-39.
14. Park CH, Bacon BR, Brittenham GM, Tavill AS. Pathology of dietary carbonyl iron overload in rats. Lab Invest. 1987; 57(5):555-63. .
15. Torrance JD, Bothwell TH. A simple technique for measuring storage iron concentrations in formalinised liver samples. S Afr J Med Sci. 1968; 33(1):9-11. .
16. Young DS, Hicks JM. Method for the Automatic Determination of Serum Iron. J Clin Pathol. 1965; 18:98-102.
17. Ramsay WN. The determination of the total iron-binding capacity of serum. Clin Chim Acta. 1957; 2 (3):221-6. .
18. Babson AL, Kleinman NM. A source of error in an autoanalyzer determination of serum iron. Clin Chem. 1967; 13(2):163-6. .
19. Roeser HP, Lee GR, Nacht S, Cartwright GE. The role of ceruloplasmin in iron metabolism. J Clin Invest. 1970; 49(12):2408-17. doi: 10.1172/JCI106460
20. Sunderman FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem. 1970; 16(11):903-10. .
21. Chomczynski P. Reagents and methods for isolation of purified RNA. Google Patents; 2010.
22. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46(7):678-84. doi: 10.1038/ng.2996
23. Kautz L, Jung G, Nemeth E, Ganz T. Erythroferrone contributes to recovery from anemia of inflammation. Blood. 2014; 124(16):2569-74. doi: 10.1182/blood-2014-06-584607
24. Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, Veltkamp C, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-Transferrin-bound iron. Blood. 2003; 102(1):371-6. doi: 10.1182/blood-2002-11-3610 .
25. Wilkins SJ, Frazer DM, Millard KN, McLaren GD, Anderson GJ. Iron metabolism in the hemoglobin-deficit mouse: correlation of diferric transferrin with hepcidin expression. Blood. 2006; 107(4):1659-64. doi: 10.1182/blood-2005-07-2614
26. Ranganathan PN, Lu Y, Fuqua BK, Collins JF. Immunoreactive hephaestin and ferroxidase activity are present in the cytosolic fraction of rat enterocytes. Biometals. 2012; 25(4):687-95. doi: 10.1007/s10534-012-9527-9
27. Linder MC, Houle PA, Isaacs E, Moor JR, Scott LE. Copper regulation of ceruloplasmin in copper-deficient rats. Enzyme. 1979; 24(1):23-35. .
28. Sherman AR, Tissue NT. Tissue iron, copper and zinc levels in offspring of iron-sufficient and iron-deficient rats. J Nutr. 1981; 111(2):266-75. .
29. Fields M, Lewis CG, Lure MD, Burns WA. Dietary ferric vs. ferrous iron in copper-deficient rats fed fructose-based diets. J Am Coll Nutr. 1995; 14(4):399-403. .
30. Cohen NL, Keen CL, Hurley LS, Lonnerdal B. Determinants of copper-deficiency anemia in rats. J Nutr. 1985; 115(6):710-25. .
31. Prohaska JR, Heller LJ. Mechanical properties of the copper-deficient rat heart. J Nutr. 1982; 112 (11):2142-50. .
32. Merza H, Sood N, Sood R. Idiopathic hyperzincemia with associated copper deficiency anemia: A diagnostic dilemma. Clin Case Rep. 2015; 3(10):819-22. doi: 10.1002/ccr3.344
33. Prasad R, Hawthorne B, Durai D, McDowell I. Zinc in denture adhesive: A rare cause of copper deficiency in a patient on home parenteral nutrition. BMJ Case Rep. 2015; 2015. doi: 10.1136/bcr-2015-211390 .
34. Klevay LM. Iron overload can induce mild copper deficiency. J Trace Elem Med Biol. 2001; 14(4):237-40 doi: 10.1016/S0946-672X(01)80009-2 .
35. Klevay LM. IHD from copper deficiency: A unified theory. Nutr Res Rev. 2016:1-8. doi: 10.1017/S0954422416000093 .
36. Yu F, Hao S, Yang B, Zhao Y, Zhang R, Zhang W, et al. Insulin resistance due to dietary iron overload disrupts inner hair cell ribbon synapse plasticity in male mice. Neurosci Lett. 2015; 597:183-8. doi: 10. 1016/j.neulet.2015.04.049 .
37. Dongiovanni P, Ruscica M, Rametta R, Recalcati S, Steffani L, Gatti S, et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol. 2013; 182(6):2254-63. doi: 10.1016/j. ajpath.2013.02.019 .
38. Mackinnon M, Clayton C, Plummer J, Ahern M, Cmielewski P, Ilsley A, et al. Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetrachloride model. Hepatology. 1995; 21(4):1083-8. .
39. Nam H, Knutson MD. Effect of dietary iron deficiency and overload on the expression of ZIP metal-ion transporters in rat liver. Biometals. 2012; 25(1):115-24. doi: 10.1007/s10534-011-9487-5
40. Coffey R, Nam H, Knutson MD. Microarray analysis of rat pancreas reveals altered expression of Alox15 and regenerating islet-derived genes in response to iron deficiency and overload. PLoS One. 2014; 9(1):e86019. doi: 10.1371/journal.pone.0086019
41. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992; 12(12):5447-54.
42. Wang GL, Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood. 1993; 82(12):3610-5. .
43. Matak P, Zumerle S, Mastrogiannaki M, El Balkhi S, Delga S, Mathieu JR, et al. Copper deficiency leads to anemia, duodenal hypoxia, upregulation of HIF-2α and altered expression of iron absorption genes in mice. PLoS One. 2013; 8(3):e59538. doi: 10.1371/journal.pone.0059538
44. Wallace DF, Summerville L, Lusby PE, Subramaniam VN. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut. 2005; 54(7):980-6. doi: 10.1136/gut.2004. 062018
45. Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009; 9(3):217-27. doi: 10.1016/j.cmet.2009.01.010
46. Floege J. Phosphate binders in chronic kidney disease: A systematic review of recent data. J Nephrol. 2016. doi: 10.1007/s40620-016-0266-9 .
47. Delmez JA, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis. 1992; 19(4):303-17. .
48. Matsuo A, Iida A, Tanimoto M, Matsushita M, Miyamoto K. The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats. Ren Fail. 2014; 36 (8):1291-7. doi: 10.3109/0886022X.2014.930491 .
49. Pai AB, Jang SM, Wegrzyn N. Iron-based phosphate binders-A new element in management of hyperphosphatemia. Expert Opin Drug Metab Toxicol. 2016; 12(1):115-27. doi: 10.1517/17425255.2016. 1110573 .
50. Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, et al. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial. Am J Kidney Dis. 2015; 66(3):479-88. doi: 10.1053/j.ajkd.2015.03.013 .